Lotus Bio Technology Development Stock Net Income
| LBTD Stock | USD 0.01 0.00 0.00% |
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lotus Bio Technology, as well as the relationship between them.
Lotus Bio-Technology's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Lotus Bio-Technology's valuation are provided below:Lotus Bio Technology Development does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Lotus |
Lotus Bio-Technology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lotus Bio-Technology's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lotus Bio-Technology.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in Lotus Bio-Technology on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding Lotus Bio Technology Development or generate 0.0% return on investment in Lotus Bio-Technology over 90 days. Lotus Bio-Technology is related to or competes with Silver Elephant, York Harbour, and Romios Gold. Lotus Bio-Technology Development Corp., a bio-technology development company, focuses on refining organic materials, and... More
Lotus Bio-Technology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lotus Bio-Technology's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lotus Bio Technology Development upside and downside potential and time the market with a certain degree of confidence.
Lotus Bio-Technology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lotus Bio-Technology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lotus Bio-Technology's standard deviation. In reality, there are many statistical measures that can use Lotus Bio-Technology historical prices to predict the future Lotus Bio-Technology's volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lotus Bio-Technology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lotus Bio Technology Backtested Returns
We have found three technical indicators for Lotus Bio-Technology, which you can use to evaluate the volatility of the firm. The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Lotus Bio-Technology are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Lotus Bio Technology Development has no correlation between past and present. Overlapping area represents the amount of predictability between Lotus Bio-Technology time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lotus Bio Technology price movement. The serial correlation of 0.0 indicates that just 0.0% of current Lotus Bio-Technology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Lotus Bio Technology Development reported net income of (19,550). This is 99.84% lower than that of the Media (discontinued effective close of September 28, 2018) sector and 100.01% lower than that of the Consumer Discretionary industry. The net income for all United States stocks is 100.0% higher than that of the company.
Lotus Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lotus Bio-Technology's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Lotus Bio-Technology could also be used in its relative valuation, which is a method of valuing Lotus Bio-Technology by comparing valuation metrics of similar companies.Lotus Bio is currently under evaluation in net income category among its peers.
Lotus Fundamentals
| Return On Asset | -4.21 | |||
| Current Valuation | 31.31 M | |||
| Shares Outstanding | 782.77 M | |||
| Shares Owned By Insiders | 60.40 % | |||
| Price To Earning | (1.71) X | |||
| Net Income | (19.55 K) | |||
| Cash And Equivalents | 1 | |||
| Total Debt | 16.68 K | |||
| Cash Flow From Operations | (17.75 K) | |||
| Beta | -1.44 | |||
| Market Capitalization | 13.78 M | |||
| Total Asset | 5.46 K | |||
| Retained Earnings | (931 K) | |||
| Working Capital | (68 K) | |||
| Current Liabilities | 68 K | |||
| Net Asset | 5.46 K |
About Lotus Bio-Technology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lotus Bio Technology Development's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lotus Bio-Technology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lotus Bio Technology Development based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Lotus Pink Sheet
Lotus Bio-Technology financial ratios help investors to determine whether Lotus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lotus with respect to the benefits of owning Lotus Bio-Technology security.